Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cells
One of the most common cancers that occur in females is breast cancer. Despite the
significant leaps and bounds that have been made in treatment of breast cancer, the disease …
significant leaps and bounds that have been made in treatment of breast cancer, the disease …
Advancements in solid lipid nanoparticles and nanostructured lipid carriers for breast cancer therapy
H Marwah, HK Dewangan - Current pharmaceutical design, 2024 - benthamdirect.com
Solid Lipid Nanocarriers (SLNs) offer a promising avenue for breast cancer treatment, a
disease that accounts for 12.5% of global cancer cases. Despite strides in combined …
disease that accounts for 12.5% of global cancer cases. Despite strides in combined …
Lipid-based nanocarriers for breast cancer treatment–comprehensive review
SV Talluri, G Kuppusamy, VVSR Karri, S Tummala… - Drug …, 2016 - Taylor & Francis
Breast cancer is the second leading cancer-related disease as the most common non-
cutaneous malignancy among women. Curative options for breast cancer are limited …
cutaneous malignancy among women. Curative options for breast cancer are limited …
Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer
Breast cancer (BC) is the most extensively accounted malignancy among the women across
the globe and is treatable in 70–80% of patients with early-stage, non-metastatic cancer …
the globe and is treatable in 70–80% of patients with early-stage, non-metastatic cancer …
Leveraging nanostructured lipid carriers to enhance targeted delivery and efficacy in breast cancer therapy: a comprehensive review
N Naseem, P Kushwaha, F Haider - Naunyn-Schmiedeberg's Archives of …, 2024 - Springer
Cancer, characterized by uncontrolled cell growth and proliferation, continues to be a major
global health concern. Breast cancer, the most commonly diagnosed cancer among women …
global health concern. Breast cancer, the most commonly diagnosed cancer among women …
Overview of solid lipid nanoparticles in breast cancer therapy
Lipid nanoparticles (LNPs), composed of ionized lipids, helper lipids, and cholesterol,
provide general therapeutic effects by facilitating intracellular transport and avoiding …
provide general therapeutic effects by facilitating intracellular transport and avoiding …
Lipid-based nanocarriers for cancer and tumor treatment
MT Ansari, TA Ramlan, NN Jamaluddin… - Current …, 2020 - ingentaconnect.com
Cancer and tumor have been major reasons for numerous deaths in this century across the
world. Many strategies have been designed to treat, diagnose, or prevent cancer. The …
world. Many strategies have been designed to treat, diagnose, or prevent cancer. The …
Lipid-based nanomaterials for drug delivery systems in breast cancer therapy
Globally, breast cancer is one of the most prevalent diseases, inducing critical intimidation to
human health. Lipid-based nanomaterials have been successfully demonstrated as drug …
human health. Lipid-based nanomaterials have been successfully demonstrated as drug …
Challenges and emerging strategies for next generation liposomal based drug delivery: an account of the breast cancer conundrum
A Moudgil, R Salve, V Gajbhiye… - Chemistry and Physics of …, 2023 - Elsevier
The global cancer burden is witnessing an upsurge with breast cancer surpassing other
cancers worldwide. Furthermore, an escalation in the breast cancer caseload is also …
cancers worldwide. Furthermore, an escalation in the breast cancer caseload is also …
Liposomes: Ideal drug delivery systems in breast cancer
Breast cancer (BC) has been recognized as the most common type of cancer in females
across the world, accounting for 12% of each cancer case. In this sense, better diagnosis …
across the world, accounting for 12% of each cancer case. In this sense, better diagnosis …